• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    416.66 Up 2.02(0.49%) Jan 30, 4:00PM EST
    |After Hours : 418.33 Up 1.67 (0.40%) Jan 30, 6:29PM EST
    Add to Portfolio
    Prev Close:414.64
    Open:410.88
    Bid:417.00 x 100
    Ask:421.41 x 500
    1y Target Est:431.91
    Beta:1.63
    Next Earnings Date:10-Feb-15REGN Earnings announcement
    Day's Range:410.60 - 424.74
    52wk Range:269.50 - 437.64
    Volume:1,060,028
    Avg Vol (3m):803,518
    Market Cap:42.00B
    P/E (ttm):142.45
    EPS (ttm):2.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    REGNUp 0.49%42.00B
    AMGNDown 2.63%115.72B
    NVSDown 1.77%233.63B
    RHHBYDown 1.79%N/A

    Key Statistics

    Forward P/E (1 yr):35.37
    P/S (ttm):15.91
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :10.00
    Quarterly EPS Est (Dec-14) :2.78
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):2.26

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback